BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21098714)

  • 1. Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells.
    Martin-Orozco N; Li Y; Wang Y; Liu S; Hwu P; Liu YJ; Dong C; Radvanyi L
    Cancer Res; 2010 Dec; 70(23):9581-90. PubMed ID: 21098714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
    Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
    Front Immunol; 2018; 9():2227. PubMed ID: 30319662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.
    Niu J; Jiang C; Li C; Liu L; Li K; Jian Z; Gao T
    Cancer Immunol Immunother; 2011 Aug; 60(8):1109-18. PubMed ID: 21547596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICOS
    Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
    Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
    Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
    J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
    Yu Y; Huang R; Zong X; He X; Mo W
    BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity.
    Stroopinsky D; Avivi I; Rowe JM; Avigan D; Katz T
    Eur J Immunol; 2009 Oct; 39(10):2703-15. PubMed ID: 19634189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.
    Curran TA; Jalili RB; Farrokhi A; Ghahary A
    Immunobiology; 2014 Jan; 219(1):17-24. PubMed ID: 23891282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
    Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
    Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infusion of ex vivo expanded homologous CD4⁺;CD25⁺; regulatory T cells promotes the susceptibility to tumor in mice].
    Guo T; Luo S; Xu J; Dai J; Liu Z; Gao X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):466-70. PubMed ID: 24796739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion.
    St Rose MC; Taylor RA; Bandyopadhyay S; Qui HZ; Hagymasi AT; Vella AT; Adler AJ
    Immunol Cell Biol; 2013 Feb; 91(2):173-83. PubMed ID: 23295363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxp3 processing by proprotein convertases and control of regulatory T cell function.
    de Zoeten EF; Lee I; Wang L; Chen C; Ge G; Wells AD; Hancock WW; Ozkaynak E
    J Biol Chem; 2009 Feb; 284(9):5709-16. PubMed ID: 19117830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.
    Han Y; Guo Q; Zhang M; Chen Z; Cao X
    J Immunol; 2009 Jan; 182(1):111-20. PubMed ID: 19109141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased suppression of CD8
    Giri PS; Dwivedi M; Begum R
    Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
    Wang ZH; Zhu JY; Li T; Leng XS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.